Related Experiment Video

Updated: Oct 31, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.0K

Analysis of perinatal coagulation function in preeclampsia

Chang Xu1, YunHui Li, Wen Zhang

  • 1Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.

Medicine
|June 30, 2021
PubMed

Insights

Preeclampsia (PE) patients exhibit altered coagulation, with lower clotting factors and platelet counts, and higher fibrinolysis markers. Postpartum day 1 shows a pro-hemorrhagic state, increasing risks for mothers.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Perinatal Medicine

Background:

  • Preeclampsia (PE) is a serious pregnancy complication.
  • Dynamic changes in coagulation function during the perinatal period in PE are not fully understood.
  • Understanding these changes is crucial for managing PE-related risks.

Purpose of the Study:

  • To investigate the dynamic changes in coagulation function in patients with preeclampsia (PE) during the perinatal period.
  • To compare coagulation profiles of PE patients with healthy pregnant women.
  • To identify coagulation patterns associated with increased risk of adverse outcomes in PE.

Main Methods:

  • Prospective study involving 290 PE patients and 256 healthy pregnant women.
  • Coagulation indexes including PT, APTT, TT, FIB, PLT, MPV, PCT, DD, FDP, and MA were measured.
  • Data collected during the prenatal period and at 1 and 3 days postpartum.

Main Results:

  • PE patients showed decreased PT, FIB, PLT, MPV, PCT, MA, and CI, with increased APTT, TT, DD, PDW, and K values pre-delivery compared to controls.
  • Postpartum day 1 in PE patients revealed lower APTT and FIB, and higher TT, DD, and FDP compared to prenatal and postpartum day 3.
  • PCT and MPV were highest prenatally in PE patients.

Conclusions:

  • PE patients exhibit a state of relative hypocoagulation and hyperfibrinolysis on postpartum day 1.
  • This altered coagulation state increases the risk of postpartum hemorrhage and other adverse outcomes.
  • Dynamic monitoring of coagulation function is essential for managing PE patients.

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

10.9K
A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function10:44

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function

Published on: June 2, 2019

6.0K

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.6K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.3K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.8K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
10.5K